Gefitinib-d8
| CAT. No. | CP-IL0225 |
|---|---|
| CAS. No. | 857091-32-8 |
| Mol. F. | C22H16D8ClFN4O3 |
| Mol. Wt. | 454.95 |
| Stock Status | Please Enquire |
- Synonyms: NA
- Chemical Name: N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-(morpholino-d8)propoxy)quinazolin-4-amine
Request for Quotation : Gefitinib-d8
Related Products
| CAT. No. | CP-G14000 |
|---|---|
| CAS. No. | 184475-35-2 |
| Mol. F. | C22H24ClFN4O3 |
| Mol. Wt. | 446.91 |
| Stock Status: | In Stock |
| CAT. No. | CP-G14001 |
|---|---|
| CAS. No. | 199327-61-2 |
| Mol. F. | C16H21N3O4 |
| Mol. Wt. | 319.36 |
| Stock Status: | Custom Synthesis |
| CAT. No. | CP-G14002 |
|---|---|
| CAS. No. | 1603814-04-5 |
| Mol. F. | C22H24ClFN4O3 |
| Mol. Wt. | 446.91 |
| Stock Status: | Custom Synthesis |
| CAT. No. | CP-G14003 |
|---|---|
| CAS. No. | 847949-51-3 |
| Mol. F. | C22H24ClFN4O4 |
| Mol. Wt. | 462.91 |
| Stock Status: | Custom Synthesis |
| CAT. No. | CP-G14004 |
|---|---|
| CAS. No. | 788136-89-0 |
| Mol. F. | C17H13ClFN3O3 |
| Mol. Wt. | 361.76 |
| Stock Status: | In Stock |
| CAT. No. | CP-G14005 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C22H23ClFN5O4 |
| Mol. Wt. | 475.91 |
| Stock Status: | Please Enquire |
| CAT. No. | CP-G49008 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C29H43N9O4 |
| Mol. Wt. | 581.72 |
| Stock Status: | Please Enquire |
| CAT. No. | CP-G49009 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C29H42N10O5 |
| Mol. Wt. | 610.72 |
| Stock Status: | Please Enquire |
| CAT. No. | CP-G49010 |
|---|---|
| CAS. No. | NA |
| Mol. F. | C29H43N9O4 |
| Mol. Wt. | 581.72 |
| Stock Status: | Please Enquire |
| CAT. No. | CP-G14009 |
|---|---|
| CAS. No. | 847949-56-8 |
| Mol. F. | C20H22ClFN4O3 |
| Mol. Wt. | 420.87 |
| Stock Status: | Custom Synthesis |
| CAT. No. | CP-G14010 |
|---|---|
| CAS. No. | 847949-49-9 |
| Mol. F. | C21H22ClFN4O3 |
| Mol. Wt. | 432.88 |
| Stock Status: | Custom Synthesis |
| CAT. No. | CP-G14011 |
|---|---|
| CAS. No. | 847949-50-2 |
| Mol. F. | C22H25ClN4O4 |
| Mol. Wt. | 444.92 |
| Stock Status: | Custom Synthesis |
